MSC therapy reduces oxidative stress, a key feature of major depressive disorder (MDD), by generating antioxidants such as hydrogen sulfide (H2S), which upregulates Sirt1 and modulates inflammatory cytokines [35]. The gene discussed is SIRT1; the disease is major depressive disorder.